Clinical trials
Fallopian Tube Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
70 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 70 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gynecologic Oncology Group | 6 |
| AltaRex | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| GOG Foundation | 2 |
| Herbert Irving Comprehensive Cancer Center | 2 |
| Lee's Pharmaceutical Limited | 2 |
| Medical Research Council | 2 |
| Royal Surrey County Hospital NHS Foundation Trust | 2 |
| Seoul National University Hospital | 2 |
| Shanghai Gynecologic Oncology Group | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 70 |
| Ovarian Neoplasms | 55 |
| Carcinoma, Ovarian Epithelial | 29 |
| Endometrial Neoplasms | 6 |
| Uterine Cervical Neoplasms | 6 |
| Breast Neoplasms | 3 |
| Neoplasms | 3 |
| Peritoneal Neoplasms | 3 |
| Recurrence | 3 |
| Vulvar Neoplasms | 3 |
Trials
Showing 26 to 50 of 70. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.